NASDAQ:BIOX

Bioceres Crop Solutions (BIOX) Stock Price, News & Analysis

$11.97
-0.15 (-1.24%)
(As of 04/22/2024 ET)
Today's Range
$11.70
$12.20
50-Day Range
$11.97
$13.46
52-Week Range
$9.76
$14.20
Volume
44,000 shs
Average Volume
61,304 shs
Market Capitalization
$751.72 million
P/E Ratio
37.41
Dividend Yield
N/A
Price Target
$23.00

Bioceres Crop Solutions MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
92.1% Upside
$23.00 Price Target
Short Interest
Bearish
1.11% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
182.22%
From $0.45 to $1.27 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.98 out of 5 stars

Consumer Staples Sector

80th out of 134 stocks

Agricultural Chemicals Industry

6th out of 10 stocks

BIOX stock logo

About Bioceres Crop Solutions Stock (NASDAQ:BIOX)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

BIOX Stock Price History

BIOX Stock News Headlines

[Shocking] Elon Musk’s Plan To End Banks
Leaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030.
Bioceres Needs To Add Clarity Around Borrowings
Bioceres Crop Solutions Corp
[Shocking] Elon Musk’s Plan To End Banks
Leaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030.
Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp (BIOX)
Earnings Preview For Bioceres Crop Solutions
Bioceres Crop Solutions Corp. (BIOX)
Beware Of Impending Dilution At Bioceres
Earnings Outlook For Bioceres Crop Solutions
Bioceres Crop Solutions Corp BIOX
Bioceres Crop Solutions Corp. (KYG1117K1141.SG)
See More Headlines
Receive BIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioceres Crop Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Today
4/22/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Agricultural chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOX
Fax
N/A
Employees
447
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.00
High Stock Price Target
$25.00
Low Stock Price Target
$21.00
Potential Upside/Downside
+92.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$18.78 million
Pretax Margin
5.55%

Debt

Sales & Book Value

Annual Sales
$419.80 million
Cash Flow
$0.57 per share
Book Value
$5.26 per share

Miscellaneous

Free Float
N/A
Market Cap
$751.72 million
Optionable
Optionable
Beta
0.58
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Jose A. Roque
    General Counsel
  • Alex Garcia
    Managing Director of Seeds
  • Dr. Federico Trucco Ph.D. (Age 47)
    Executive Chairman & CEO
    Comp: $131.16k
  • Mr. Enrique López Lecube (Age 42)
    CFO & Executive Director
    Comp: $129.89k
  • Mr. Jorge Wagner (Age 55)
    Chief Operating Officer
    Comp: $165.6k
  • Ms. Paula Savanti
    Head of Investor Relations
  • Ms. Gloria Montaron Estrada (Age 53)
    Executive Director
  • Mr. Ricardo Luis Yapur (Age 65)
    Managing Director of Latam Unit & Chief Commercial Officer
    Comp: $260k
  • Mr. Matti Tiainen (Age 34)
    Managing Director of North America & Europe

BIOX Stock Analysis - Frequently Asked Questions

Should I buy or sell Bioceres Crop Solutions stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bioceres Crop Solutions in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BIOX shares.
View BIOX analyst ratings
or view top-rated stocks.

What is Bioceres Crop Solutions' stock price target for 2024?

2 Wall Street analysts have issued 1-year target prices for Bioceres Crop Solutions' shares. Their BIOX share price targets range from $21.00 to $25.00. On average, they expect the company's share price to reach $23.00 in the next twelve months. This suggests a possible upside of 92.1% from the stock's current price.
View analysts price targets for BIOX
or view top-rated stocks among Wall Street analysts.

How have BIOX shares performed in 2024?

Bioceres Crop Solutions' stock was trading at $13.73 at the beginning of 2024. Since then, BIOX shares have decreased by 12.8% and is now trading at $11.97.
View the best growth stocks for 2024 here
.

Are investors shorting Bioceres Crop Solutions?

Bioceres Crop Solutions saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 342,600 shares, an increase of 17.7% from the March 15th total of 291,200 shares. Based on an average trading volume of 65,900 shares, the days-to-cover ratio is presently 5.2 days. Approximately 1.1% of the shares of the stock are sold short.
View Bioceres Crop Solutions' Short Interest
.

When is Bioceres Crop Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our BIOX earnings forecast
.

How were Bioceres Crop Solutions' earnings last quarter?

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) released its quarterly earnings results on Thursday, February, 8th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.02. The company earned $140.30 million during the quarter, compared to analysts' expectations of $108.97 million. Bioceres Crop Solutions had a trailing twelve-month return on equity of 5.96% and a net margin of 4.36%. During the same quarter in the prior year, the company earned ($0.14) EPS.

What ETFs hold Bioceres Crop Solutions' stock?

ETFs with the largest weight of Bioceres Crop Solutions (NASDAQ:BIOX) stock in their portfolio include Ballast Small/Mid Cap ETF (MGMT) and Global X MSCI Argentina ETF (ARGT).Global X AgTech & Food Innovation ETF (KROP).

What other stocks do shareholders of Bioceres Crop Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bioceres Crop Solutions investors own include Arcadia Biosciences (RKDA), ChromaDex (CDXC), Trevena (TRVN), Advanced Micro Devices (AMD), Amyris (AMRS), Celldex Therapeutics (CLDX), Chimerix (CMRX), CTI BioPharma (CTIC).

When did Bioceres Crop Solutions IPO?

Bioceres Crop Solutions (BIOX) raised $130 million in an IPO on Wednesday, February 7th 2018. The company issued 11,800,000 shares at a price of $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey acted as the underwriters for the IPO and Mirabaud Securities was co-manager.

Who are Bioceres Crop Solutions' major shareholders?

Bioceres Crop Solutions' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Fourth Sail Capital LP (2.59%).

How do I buy shares of Bioceres Crop Solutions?

Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BIOX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners